KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

In inpatients with COVID-19 who need supplemental oxygen, lenzilumab increased ventilation-free survival.

Vincent J Mariano, Eleftherios Mylonakis

Ann Intern Med 175(4) JC39

PMID35377717
PMCID-
DOI10.7326/J22-0019
发表日期2022-04-04
摘要

摘要

Temesgen Z, Burger CD, Baker J, et al. Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial. Lancet Respir Med. 2022;10:237-46. 34863332.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。